Proof-of-concept (PoC) Study of APD515

NCT01331746 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Xerostomia in Advanced Cancer Patients

Interventions

DRUG: APD515
DRUG: Placebo

Sponsor

Acacia Pharma Ltd